Suppr超能文献

大鼠中作为烟碱样受体拮抗剂的NMDA受体通道阻滞剂的药物辨别分析

Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.

作者信息

Zakharova E S, Danysz W, Bespalov A Y

机构信息

Laboratory of Behavioral Pharmacology, Institute of Pharmacology, Pavlov Medical University, St. Petersburg 197089, Russia.

出版信息

Psychopharmacology (Berl). 2005 Apr;179(1):128-35. doi: 10.1007/s00213-004-2067-4. Epub 2005 Jan 29.

Abstract

RATIONALE

Antagonists acting at the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors inhibit various phenomena associated with exposures to nicotine (e.g., tolerance, sensitization, dependence, and intravenous self-administration). These effects are often discussed in terms of nicotine-induced glutamate release with subsequent glutamate-dependent stimulation of dopamine metabolism and neuronal plasticity in brain areas critically involved in drug-addiction mechanisms. However, it is also well established that certain types of NMDA receptor antagonists (channel blockers) potently bind to nicotinic receptors and may act as nicotinic receptor antagonists.

OBJECTIVE

The present study aimed to evaluate the discriminative-stimulus effects of the NMDA receptor channel blockers (+)MK-801, dextromethorphan, and memantine in rats trained to discriminate nicotine from its vehicle.

METHODS

Adult male Wistar rats were trained to discriminate 0.6 mg/kg nicotine from saline under a two-lever, fixed-ratio 10 schedule of food reinforcement. During test sessions, injections of (+)MK-801 (0.03--0.3 mg/kg, i.p.), dextromethorphan (30 mg/kg, s.c.), or memantine (1--10 mg/kg, i.p.) were co-administered with s.c. nicotine (0.075--0.6 mg/kg; interaction tests) or saline (generalization tests). Additional interaction and generalization tests were conducted with the selective nicotinic receptor antagonists mecamylamine (0.1--3 mg/kg, s.c.) and MRZ 2/621 (0.3--10 mg/kg, i.p.), and the mGlu5 receptor antagonist MPEP (3--10 mg/kg, i.p.).

RESULTS

In generalization tests, none of the compounds produced any appreciable levels of substitution for nicotine. The nicotine discriminative-stimulus control was dose dependently attenuated by mecamylamine (ED(50)=0.67 mg/kg) and MRZ 2/621 (ED(50)=9.7 mg/kg). Both agents produced a marked downward shift in the nicotine dose-response curve. Memantine and MPEP slightly attenuated nicotine discriminative-stimulus effects, while (+)MK-801 and dextromethorphan did not affect the nicotine-appropriate responding.

CONCLUSIONS

NMDA receptor channel blockers, such as (+)MK-801, dextromethorphan, and memantine, have minimal interactions with the discriminative-stimulus effects of nicotine.

摘要

原理

作用于谷氨酸受体N-甲基-D-天冬氨酸(NMDA)亚型的拮抗剂可抑制与接触尼古丁相关的各种现象(如耐受性、敏化、依赖性和静脉自我给药)。这些效应通常根据尼古丁诱导的谷氨酸释放来讨论,随后谷氨酸依赖性刺激多巴胺代谢以及在药物成瘾机制中起关键作用的脑区中的神经元可塑性。然而,也有充分证据表明,某些类型的NMDA受体拮抗剂(通道阻滞剂)能与烟碱受体强力结合,且可能作为烟碱受体拮抗剂发挥作用。

目的

本研究旨在评估NMDA受体通道阻滞剂(+)MK-801、右美沙芬和美金刚对训练区分尼古丁与其溶媒的大鼠的辨别刺激效应。

方法

成年雄性Wistar大鼠在双杠杆、固定比率10的食物强化程序下接受训练,以区分0.6毫克/千克尼古丁和生理盐水。在测试期间,将(+)MK-801(0.03 - 0.3毫克/千克,腹腔注射)、右美沙芬(30毫克/千克,皮下注射)或美金刚(1 - 10毫克/千克,腹腔注射)与皮下注射的尼古丁(0.075 - 0.6毫克/千克;相互作用测试)或生理盐水(泛化测试)联合给药。使用选择性烟碱受体拮抗剂美加明(0.1 - 3毫克/千克,皮下注射)和MRZ 2/621(0.3 - 10毫克/千克,腹腔注射)以及mGlu5受体拮抗剂MPEP(3 - 10毫克/千克,腹腔注射)进行额外的相互作用和泛化测试。

结果

在泛化测试中,没有一种化合物产生任何明显程度的尼古丁替代作用。尼古丁辨别刺激控制被美加明(半数有效剂量[ED50]=0.67毫克/千克)和MRZ 2/621(ED50=9.7毫克/千克)剂量依赖性减弱。两种药物均使尼古丁剂量反应曲线明显向下移动。美金刚和MPEP略微减弱尼古丁辨别刺激效应,而(+)MK-801和右美沙芬不影响对尼古丁的适当反应。

结论

NMDA受体通道阻滞剂,如(+)MK-801、右美沙芬和美金刚,与尼古丁的辨别刺激效应的相互作用极小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验